Folate, homocysteine and the cardiac neural crest

Thomas H Rosenquist1

  • 1Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA. throsenq@unmc.edu

Insights

Perigestational folate supplementation effectively reduces congenital heart defects (CHD) by supporting cardiac neural crest development. Further research into folate and homocysteine roles may yield new strategies to prevent CHD.

Area of Science:

  • Developmental Biology
  • Nutritional Neuroscience
  • Cardiovascular Research

Background:

  • Congenital heart defects (CHD) are the most prevalent birth defects globally.
  • Perigestational folate supplementation (PFS) is the primary intervention for CHD prevention.
  • Cardiac neural crest (CNC) development is crucial for normal heart formation and is sensitive to folate and homocysteine levels.

Purpose of the Study:

  • To review the roles of folate and homocysteine in cardiac neural crest (CNC) development.
  • To explore mechanisms by which folate influences CNC development, including one-carbon metabolism and gene regulation.
  • To examine the detrimental effects of hyperhomocysteinemia on CNC development.

Main Methods:

  • Literature review focusing on the molecular and cellular mechanisms of folate and homocysteine in embryonic heart development.
  • Analysis of existing research on the impact of folate and homocysteine on cardiac neural crest cell (CNCC) function.
  • Synthesis of evidence linking folate metabolism and homocysteine levels to CHD etiology.

Main Results:

  • Folate is essential for CNC development, supporting critical processes like mitosis and gene methylation.
  • Hyperhomocysteinemia disrupts CNC development through oxidative stress, impaired gene methylation, protein homocysteinylation, and NMDA receptor binding.
  • The folate receptor plays a direct role in regulating gene expression relevant to CNC development.

Conclusions:

  • Understanding the intricate roles of folate and homocysteine in CNC development is key to CHD prevention.
  • Targeted research advancements beyond PFS could lead to novel strategies for preventing CHD.
  • Interventions aimed at optimizing folate status and mitigating homocysteine effects hold promise for reducing the incidence of congenital heart defects.